Cholesterol‐Derived Mannosylated Polypeptide‐Formed Lipid Nanoparticles for Efficient in Vivo mRNA Delivery

Page view(s)
0
Checked on
Cholesterol‐Derived Mannosylated Polypeptide‐Formed Lipid Nanoparticles for Efficient in Vivo mRNA Delivery
Title:
Cholesterol‐Derived Mannosylated Polypeptide‐Formed Lipid Nanoparticles for Efficient in Vivo mRNA Delivery
Journal Title:
Small Methods
Keywords:
Publication Date:
27 May 2025
Citation:
Zeng, J.-Y., Lingesh, S., Krishnan, N. B., Loong, B. S. Y., Liu, M., Chen, Q., & Yang, Y. Y. (2025). Cholesterol‐Derived Mannosylated Polypeptide‐Formed Lipid Nanoparticles for Efficient in Vivo mRNA Delivery. Small Methods, 9(6). Portico. https://doi.org/10.1002/smtd.202401712
Abstract:
Effective delivery of lipid nanoparticles (LNPs)‐based mRNA vaccines to antigen presenting cells (APCs) is important for eliciting potent immune responses. However, most LNPs‐based mRNA vaccines usually suffer from insufficient accumulation in APCs due to the lack of active targeting capability, leading to the limited efficacy and the need for high injection dose. In this study, a series of cholesterol‐derived mannopolypeptide (CPSM) and cholesterol‐conjugated mannose (CM) derivatives is synthesized to prepare mannosylated LNPs for efficient mRNA delivery. The co‐assembly of CPSM and/or CM is demonstrated with ionizable lipid, helper lipid, and cholesterol into LNPs provides the colloidal stability of LNPs, and endows LNPs the ability to target APCs. The leading mannosylated LNPs including CPSM‐LNP and CM/CPSM‐LNP exhibit efficient mRNA transfection ability in dendritic cells and mice. Specifically, CPSM‐LNP and CM/CPSM‐LNP show preferential accumulation in the lymph nodes compared with commercial ALC‐LNP from Pfizer/BioNTech's COVID‐19 mRNA vaccine formulation. This study presents a straightforward yet effective strategy to synthesize cholesterol‐derived mannopolypeptides and prepare mannosylated LNPs for successful in vivo mRNA delivery.
License type:
Publisher Copyright
Funding Info:
This research / project is supported by the Agency for Science, Technology and Research (A*STAR) - Industry Alignment Fund - Pre-positioning
Grant Reference no. : H22J1a0050

This research / project is supported by the National Research Foundation Singapore - Competitive Research Programme
Grant Reference no. : CRP27-2021-0038
Description:
This is the peer reviewed version of the following article: Zeng, J.-Y., Lingesh, S., Krishnan, N. B., Loong, B. S. Y., Liu, M., Chen, Q., & Yang, Y. Y. (2025). Cholesterol‐Derived Mannosylated Polypeptide‐Formed Lipid Nanoparticles for Efficient in Vivo mRNA Delivery. Small Methods, 9(6). Portico. https://doi.org/10.1002/smtd.202401712 , which has been published in final form at https://doi.org/10.1002/smtd.202401712. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.
ISSN:
2366-9608
2366-9608
Files uploaded: